Clinical Trials Logo

Clinical Trial Summary

This study is conducted to compare the anti-VEGF effect and visual function in vitreous hemorrhage patients with diabetic macular edema after pars plana vitrectomy with inner limiting membrane peeling or not


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05529589
Study type Observational
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Jian Ma, Doctor
Phone 18858299889
Email jian_ma@zju.edu.cn
Status Recruiting
Phase
Start date February 10, 2023
Completion date October 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT00411970 - 20- Versus 23- Gauge System for Pars Plana Vitrectomy Phase 4
Completed NCT00155454 - Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy N/A
Completed NCT00000154 - Diabetic Retinopathy Vitrectomy Study (DRVS) Phase 3
Recruiting NCT05514925 - Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy Phase 4
Completed NCT02858076 - Anti-VEGF vs. Prompt Vitrectomy for VH From PDR Phase 2/Phase 3
Completed NCT00596297 - Preoperative Bevacizumab for Vitreous Hemorrhage Phase 1/Phase 2
Completed NCT00198510 - Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage Phase 3
Completed NCT01854593 - Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy Phase 4
Completed NCT04859556 - Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study N/A
Recruiting NCT01824043 - Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage Phase 4
Completed NCT01805297 - Aflibercept Injection for Proliferative Diabetic Retinopathy Phase 2
Completed NCT06383754 - Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study N/A
Not yet recruiting NCT04346095 - Oral Sedation in Vitreoretinal Surgery Phase 4
Completed NCT00996437 - Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Phase 2/Phase 3
Completed NCT00745498 - Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy N/A
Completed NCT00198497 - Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage Phase 3
Completed NCT00000162 - Branch Vein Occlusion Study Phase 3
Completed NCT05710458 - Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter N/A
Recruiting NCT05588037 - Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery N/A
Completed NCT04712786 - Refractive Changes Following Vitrectomy